JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 94: 3708-3718, 2005. First published August 17, 2005; doi:10.1152/jn.00583.2005
0022-3077/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/6/3708    most recent
00583.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Govindaiah, G.
Right arrow Articles by Cox, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Govindaiah, G.
Right arrow Articles by Cox, C. L.

Excitatory Actions of Dopamine Via D1-Like Receptors in the Rat Lateral Geniculate Nucleus

G. Govindaiah and Charles L. Cox

Department of Molecular and Integrative Physiology, University of Illinois; Department of Pharmacology, University of Illinois College of Medicine; and Beckman Institute, University of Illinois, Urbana, Illinois

Submitted 6 June 2005; accepted in final form 9 August 2005


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The excitability of relay neurons in the dorsal geniculate nucleus (dLGN) can be altered by a variety of neuromodulators. The dLGN receives substantial dopaminergic input from the brain stem, and this innervation may play a crucial role in the gating of visual information from the retina to visual neocortex. In this study, we investigated the action of dopamine on identified dLGN neurons using whole cell recording techniques. Dopamine (2–200 µM) produced a membrane depolarization in >95% of relay neurons tested but did not alter excitability of dLGN interneurons. The D1-like dopamine receptor agonist SKF38393 (2–50 µM) produced a similar depolarization in dLGN relay neurons. However, the D2-like receptor agonists, bromocriptine (25–50 µM) and PPHT (1–50 µM), did not alter the membrane potential of relay neurons. SCH23390 (5–10 µM), a D1-like receptor antagonist, attenuated the depolarizing actions of both dopamine and SKF38393. Furthermore, the excitatory actions of dopamine and SKF38393 were attenuated by ZD7288, a specific antagonist for the hyperpolarization activated mixed cation current, Ih. Our data suggest that dopamine, acting via D1-like receptors, activates Ih leading to a membrane depolarization. Through the modulation of dLGN neuronal excitability, ascending and descending activating systems may not only control the state of the thalamus such as the transition from slow-wave sleep to waking but also regulate the efficacy of information transfer during waking states.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The transfer of visual information from the retina to visual neocortex is dynamically gated by the dorsal lateral geniculate nucleus (dLGN). It involves a complex interaction between intrinsic membrane properties of these thalamic neurons and an extensive complement of nonretinal inputs to dLGN that arise from cortical and subcortical regions (Jones 1985Go; Sherman and Guillery 1996Go, 2001Go; Steriade et al. 1997Go). Input from the retina in the visual system accounts for <10% of the total synaptic inputs onto individual dLGN relay neurons (Van Horn et al. 2000Go). The majority of synaptic inputs (>90%) onto thalamic relay neurons originates from inhibitory neurons (local interneurons and thalamic reticular neurons), deep layer neocortex, and various brain stem nuclei (Sherman and Guillery 2001Go). Similar proportions of inputs have also been described in the somatosensory system (Liu et al. 1995Go). The extensive complement of nonretinal inputs to the dLGN combine to modulate the responsiveness of relay cells to their retinal inputs and thereby influences the transfer of visual information to cortex.

The innervation of thalamic nuclei by various brain stem nuclei involves several different neuromodulators: cholinergic innervation from the pedunculopontine region, noradrenergic innervation from the locus coeruleus, serotonergic innervation from the dorsal raphe nucleus, and dopaminergic innervation from the mesencephalic reticular formation (De Lima and Singer 1987Go; De Lima et al. 1985Go; Hallanger et al. 1987Go; Hughes and Mullikin 1984Go; Jones 1985Go; McCormick 1992bGo; Morrison and Foote 1986Go; Papadopoulos and Parnavelas 1990aGo,bGo). One proposed function of these brain stem afferents is the regulation of action potential discharge mode, which is related to levels of arousal as well as sleep/wake cycles (McCormick 1992aGo,bGo; Sherman and Guillery 2001Go; Steriade et al. 1993Go). Another possible functional role of these neuromodulators is to alter the transfer properties of thalamic relay in the attentive state (e.g., Albrecht et al. 1996Go; Kayama 1985Go; Zhao et al. 2002Go). Characterizing how these neuromodulators affect the properties of thalamic neurons is therefore critical in understanding the ascending modulation of thalamocortical function.

Various in vivo studies suggest the potentially important role of the neuromodulators in modifying the activity of thalamic relay neurons. Dopamine has been found to modify visual responses; however, the mechanisms underlying these actions remain unknown. In general, dopamine inhibits visually evoked unit activity in the majority of dLGN neurons in rats in vivo (Albrecht et al. 1996Go), suggesting that dopamine may modify contrast gain in dLGN. In addition, recent studies suggest that dopamine produces a concentration-dependent, biphasic response: suppression of visually evoked responses at high concentrations and facilitation of visually evoked responses at lower concentrations (Zhao et al. 2002Go). To help resolve these issues, we used intracellular recording techniques to investigate the actions of dopamine on individual dLGN neurons.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
All experimental procedures were carried out in accordance with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the University of Illinois Animal Care and Use committee. Thalamic slices were prepared from young Sprague Dawley rats (postnatal age 10–17 days) similar to that previously described (Cox and Sherman 2000Go; Govindaiah and Cox 2004Go). The animals were deeply anesthetized with pentobarbital sodium (50 mg/kg) and decapitated. The brains were quickly removed and placed into chilled (4°C), oxygenated (5% CO2-95% O2) slicing medium containing (in mM) 2.5 KCl, 1.25 NaH2PO4, 10.0 MgCl2, 2.0 CaCl2, 26.0 NaHCO3, 11.0 glucose, and 234.0 sucrose. Parasagittal or coronal slices (300- to 350-µm thick) containing the dLGN were cut using a vibrating tissue slicer, transferred to a holding chamber containing oxygenated, warm physiological saline (32°C), and incubated in physiological saline for ≥1 h prior to recording. Individual slices were transferred to a submersion type recording chamber that was maintained at 30 ± 1°C and continuously perfused (3 ml/min) with oxygenated physiological saline. The physiological saline contained (in mM) 126.0 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2.0 MgCl2, 2.0 CaCl2, 26.0 NaHCO3, and 10.0 glucose. The solution was continuously gassed with 95% O2-5% CO2 to a final pH of 7.4.

Recording procedures

Intracellular recordings, using the whole cell configuration, were obtained with the visual aid of a modified microscope equipped with differential interference contrast optics (Axioskop 2FS, Carl Zeiss). A low-power objective (5x) was used to identify specific thalamic nuclei, and a high-power (63x) water-immersion objective was used to identify individual neurons. Recording pipettes were pulled from 1.5 mm OD capillary tubing (Garner Glass, Claremont, CA) and had tip resistances of 3–6 M{Omega} when filled with an intracellular solution containing (in mM) 117.0 K-gluconate, 13.0 KCl, 1.0 MgCl2, 0.07 CaCl2, 0.1 EGTA, 10.0 HEPES, 2.0 Na-ATP, 0.4 Na-GTP, and 0.3% biocytin. The pH and osmolarity of internal solution were adjusted to 7.3 and 290 mosM, respectively. The internal solution resulted in a 10 mV junction potential that has been corrected in the voltage measures. All recordings were obtained using either an Axoclamp 2B or a Multiclamp 700A amplifier (Axon Instruments, Foster City, CA). For current-clamp recordings, an active bridge circuit was continuously monitored and if necessary, adjusted to balance the drop in potential produced by passing current through the recording electrode. Recordings included in this study had initial access resistances ranging from 7 to 15 M{Omega} and typically remained stable throughout the recording.

Drug application

Concentrated stock solutions of various pharmacological agents were originally prepared in appropriate diluents and diluted in physiological saline to a final concentration prior to use. Agonists were typically applied via a short bolus using a syringe pump (Cox and Sherman 2000Go; Govindaiah and Cox 2004Go). Dopamine and SKF38393 were prepared fresh just before application. Dopamine was prepared with 0.08% ascorbic acid to prevent oxidation. Stock solutions of SKF38393, forskolin, and KT5720 were initially made with dimethyl sulfoxide. All antagonists were bath applied 7–10 min prior to application of agonists. Dopamine and phenylephrine were purchased from Sigma (St. Louis, MO), whereas all remaining compounds were purchased from Tocris (Ellisville, MO).

Data analysis

The acquisition and analyses of data were accomplished using pClamp software (Axon Instruments). The apparent input resistance of neurons was calculated from the linear slope of the voltage-current relationship obtained by applying constant current pulses ranging from –100 to +40 pA (800-ms duration). A change in the apparent input resistance of the neuron during agonist application was determined by alterations in the membrane response to single-intensity hyperpolarizing current pulses (10–20 pA, 500 ms, 0.2 Hz). To reduce voltage-dependent changes in apparent input resistance, we would manually adjust the membrane potential using current injection at the peak of the agonist-induced depolarization to the preagonist level and then obtain our measures of the response to the hyperpolarizing current pulses. Quantitative analyses are expressed as means ± SD, and statistical significance was tested using Mann Whitney U test, Wilcoxon paired, paired Student's t-test, or one-way ANOVA unless otherwise noted. When an ANOVA test was conducted, Tukey-Kramer multiple comparisons tests were used to test differences between specific groups. P values <0.05 were considered statistically significant.

Histology

Neuronal subtypes, relay or interneurons, were confirmed by morphological reconstruction. The recording pipettes contained 0.3% biocytin, and after the recordings, individual slices were fixed overnight in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Slices were incubated overnight in an avidin-biotin-horseradish peroxidase complex (ABC Elite, Vector Labs, CA) and reacted with diaminobenzidine using established procedures to visualize recorded neurons (Cox and Sherman 2000Go; Horikawa and Armstrong 1988Go). Slices were then mounted with permount and the neurons were examined using bright-field microscopy.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Dopamine depolarizes dLGN relay neurons

Whole cell current- and voltage-clamp recordings were obtained from a total of 167 relay neurons and 17 interneurons in dLGN. The relay and interneurons were identified by their morphological and electrophysiological properties (Fig. 2, A, ii and iii, and C, ii and iii) and were similar to those described previously (Govindaiah and Cox 2004Go; Pape and McCormick 1995Go; Williams et al. 1996Go; Zhu et al. 1999Go). All recorded cells were filled with biocytin for post hoc reconstruction, and among these, the morphology of 113 relay neurons and 9 interneurons were recovered. The membrane potential and input resistances of relay neurons were –65.2 ± 3.2 mV and 334 ± 106 M{Omega}, respectively. Interneurons had a lower average resting membrane potential of –56.6 ± 6.9 mV (n = 17; P < 0.01, Mann-Whitney test) and a greater apparent input resistance (653 ± 224 M{Omega}; n = 8; P < 0.01, Mann-Whitney test).



View larger version (50K):
[in this window]
[in a new window]
 
FIG. 2. The excitatory actions of dopamine are mediated through D1-like dopamine receptors. Ai: in a current-clamp recording from a dLGN relay neuron in the presence of 1 µM TTX, dopamine (50 µM) produces a long-lasting depolarization. Subsequent application of SKF38393 (5 µM), a D1-like specific agonist, also depolarizes the neuron. In contrast, the D2-like agonists, (±)-2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin hydrochloride (25 µM) and bromocriptine (25 µM), did not alter the membrane potential in the same cell. Aii: micrograph of dLGN relay neuron from which recordings in Ai were obtained. Calibration, 50 µm. Aiii: response of this neuron to depolarizing and hyperpolarizing current steps. Note the presence of a low-threshold calcium spike in response to hyperpolarizing current pulse (<-). B: population data illustrating the peak depolarization to different SKF38393 concentrations. The numbers in the graph represent the number of cells tested at each concentration. Ci: current-clamp recording from a dLGN interneuron. Dopamine SKF38393, and bromocriptine did not alter the membrane potential or apparent input resistance of this cell. Cii: micrograph is the interneuron from which the recordings in Ci were obtained. Note the relatively long and simple branch pattern of the dendrites. Calibration, 50 µm Ciii: membrane response to hyperpolarizing and depolarizing current steps indicate obvious depolarizing sag to hyperpolarizing current steps and the apparent lack of burst discharge.

 
Short-duration application (15–20 s) of dopamine (2–200 µM) produced a membrane depolarization with average peak amplitude of 6.1 ± 3.4 mV in almost all relay neurons tested (90/93; Fig. 1). The depolarizing action of dopamine persisted in the presence of TTX (1 µM), suggesting that dopamine is directly activating postsynaptic dopamine receptors on dLGN relay neurons and not indirectly exciting the relay neurons via suprathreshold activation of neurons presynaptic to the relay neurons (Fig. 1A). The depolarization was associated with a small but statistically nonsignificant increase in input resistance (334 ± 96 vs. 380 ± 114 M{Omega}, n = 34). The dLGN relay neurons responded to dopamine in a dose-dependent manner over the range of concentrations tested (2–200 µM; Fig. 1, B–D). The peak amplitude of the depolarizations produced by increasing concentrations of dopamine averaged 1.8 ± 1.3 (n = 10), 4 ± 1.5 (n = 15), 6.3 ± 2.2 (n = 13), 7.5 ± 3.1 (n = 24), and 8.9 ± 3.3 mV (n = 10) at 2, 10, 50, 100, and 200 µM, respectively (Fig. 1C). Overall, the dopamine-mediated depolarization significantly differed across concentrations (P < 0.001, ANOVA with Tukey-Kramer multiple comparisons). The amplitude of the depolarizations obtained with lower dopamine concentrations (2 and 10 µM) significantly differed from each of the depolarizations produced by higher dopamine concentrations (50, 100, and 200 µM, P < 0.05). However, these higher concentrations (50, 100, and 200 µM) did not significantly differ from each other. In a subset of cells (n = 12), multiple doses (2–200 µM) of dopamine were applied in the same cells at 10-min intervals. The peak amplitude of the dopamine depolarizations typically showed dose dependence (Fig. 1D).



View larger version (26K):
[in this window]
[in a new window]
 
FIG. 1. Dopamine depolarizes dorsal geniculate nucleus (dLGN) relay neurons. A: current-clamp recording from a dLGN relay neuron. Bath application of dopamine (DA, 50 µM) depolarizes the relay neuron in a reversible manner. In TTX (1 µM), the dopamine-mediated depolarization persists suggesting a postsynaptic site of action. The downward deflections represent membrane responses to 10-pA hyperpolarizing current pulses. At the peak of the dopamine-mediated depolarization, the membrane potential was manually adjusted to predopamine levels with current injection to test for alterations in apparent input resistance. B: current-clamp recording from a different relay neuron indicating the dose-dependent increase in the amplitude of depolarization when different concentrations of dopamine (2- 200 µM) were applied at 10-min intervals. C: population data illustrating the concentration dependence of the dopamine-mediated depolarization. The numbers in the graph represent the number of cells tested for each dose. D: dose-dependent increase in the amplitude of the dopamine-mediated depolarization when multiple concentrations were tested in individual cells. Each line represents a single neuron. Note the amplitude of the depolarization is positively correlated with the dopamine concentration.

 
To determine whether the excitatory actions of dopamine were restricted to dLGN relay neurons, we also tested these different agonists on 17 dLGN interneurons. Dopamine (50–200 µM, n = 13), SKF38393 (50 µM, n = 4), or bromocriptine (50 µM, n = 3) did not alter the membrane potential or input resistance in all interneurons tested (Fig. 2Ci). The resting membrane potential prior to dopamine agonist application in the interneurons averaged –63.5 ± 4.5 mV and was not significantly altered after agonist application (–62.8 ± 5.0 mV, P > 0.05, Wilcoxon test).

Depolarizing actions of dopamine are mediated through dopamine D1-like receptors

To evaluate the receptor subtype underlying the dopamine-mediated depolarization in relay neurons, we tested the actions of specific D1- and D2-like receptor agonists on the relay neurons. The D1-like receptor agonist, SKF38393 (2–50 µM), depolarized the majority of neurons tested (84%: 27/32; Fig. 2Ai). In contrast, the D2-like agonists, (±)-2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin hydrochloride (PPHT, 10–50 µM; n = 10) and bromocriptine (25–50 µM; n = 6), did not alter the membrane potential or apparent input resistance of the relay neurons (Fig. 2Ai). Similar to dopamine, the depolarizations produced by SKF38393 persisted in TTX (1 µM), and the peak amplitude of the depolarization was dose dependent: 1.3 ± 0.5 (n = 3), 3.8 ± 1.0 (n = 5), 3.8 ± 1.5 (n = 10), 4.5 ± 1.8 (n = 10), and 4.5 ± 1.9 mV (n = 4) at 2, 5, 10, 25, and 50 µM, respectively (Fig. 2B). Associated with the depolarizing action of SKF38393 (10–50 µM) was a significant decrease in the apparent input resistance of the relay neurons (pre-SKF38393: 364 ± 112 M{Omega} vs. post-SKF38393: 329 ± 106 M{Omega}; P < 0.05, paired t-test, n = 12).

To further determine the specific subtype of dopamine receptor underlying the postsynaptic depolarization in relay neurons, we tested the sensitivity of the dopamine agonist-mediated responses to the D1-like dopamine receptor antagonist SCH23390. The depolarization produced by dopamine (50–100 µM) was significantly attenuated by SCH23390 (5–10 µM; P < 0.01, n = 9; Fig. 3, A and B). The average attenuation of the dopamine-mediated depolarization was 59 ± 6% with 5 µM (n = 4) and 70 ± 11% with 10 µM SCH23390 (n = 5); however, there was no significant difference between the different SCH23390 concentrations (P > 0.05, Fig. 3B). Considering reports that SCH23390 may also act as a serotonergic receptor agonist in certain brain regions (Bourne 2001Go; Millan et al. 2001Go), it is important to note that application of SCH23390 did not significantly alter the membrane potential or input resistance of these neurons. Prior to SCH23390 application, the resting membrane potential and apparent input resistance averaged –70.4 ± 3.8 mV and 356.2 ± 72.3 M{Omega} (n = 9), respectively. After wash in of SCH23390, the membrane potential averaged –70.5 ± 3.9 and input resistance averaged 349.3 ± 57.7 M{Omega} (n = 9), neither of these were significantly different from the pre-SCH23390 condition (P > 0.5; Wilcoxon).



View larger version (33K):
[in this window]
[in a new window]
 
FIG. 3. The D1-like receptor antagonist, SCH323390, attenuates the excitatory actions of dopamine agonists. A: in TTX (1 µM), dopamine (100 µM) strongly depolarizes a relay neuron. In the presence of SCH23390 (10 µM), the dopamine-mediated depolarization is strongly attenuated. The reduction in the dopamine-mediated depolarization recovers after 20-min wash. B: summary of population data regarding the antagonistic action of SCH23390 (5–10 µM). The dopamine-mediated depolarization was significantly suppressed in SCH23390 (*, P < 0.05). There was not a significant difference between the effect of 5 and 10 µM SCH23390. C: depolarization produced by SKF38393 is attenuated by SCH23390. In a different relay neuron, SKF38393 produces a strong depolarization. In SCH23390 (10 µM), the SKF38393-mediated depolarization is almost completely blocked. D: summary of the antagonistic effect of SCH23390 on the SKF38393-mediated depolarization in a population of cells. *, P < 0.05.

 
We next tested the sensitivity of the SKF38393-mediated depolarization to the D1-like receptor antagonist SCH23390. The depolarization produced by SKF38393 was significantly attenuated by SCH23390 (2–10 µM; Fig. 3, C and D). In control conditions, SKF38393 (5–25 µM) produced a depolarization that averaged 3.7 ± 1.1 mV (n = 10). In the presence of SCH23390 (2 µM, n = 4; 10 µM, n = 6), the depolarization was significantly attenuated to 16 ± 15% of control values (P < 0.01; Fig. 3D). These data clearly demonstrate that the depolarizing actions of dopamine and SKF38393 involve the activation of D1-like dopamine receptors.

Our data using SCH23390 clearly demonstrated that the SKF38393-mediated depolarization was nearly eliminated in the presence of the antagonist; however, the blockade of the dopamine-mediated depolarization was not as complete. To test the potential cross-talk of dopamine at the concentrations tested (50–100 µM) with other catecholamine receptors, we tested the {alpha}1-adrenergic antagonist prazosin and SCH23390 on catecholamine-mediated depolarizations in relay neurons. The {alpha}1-adrenergic agonist phenylephrine (100 µM) depolarized dLGN relay neurons with average peak amplitude of 6.5 ± 2.7 mV (n = 11; Fig. 4Ai). In contrast to the actions of phenylephrine, the {alpha}2 receptor agonist clonidine (20–100 µM, n = 5; Fig. 4Aii) and the {beta}-adrenergic receptor agonist cimaterol (50–100 µM, n = 9; Fig. 4Aiii) failed to alter the membrane potential of dLGN relay neurons. The phenylephrine-mediated depolarization was significantly reduced by 91 ± 9% in the presence of the {alpha}1-adrenergic antagonist prazosin (5–25 µM; n = 5, P < 0.01; Fig. 4, Ai and B). In contrast, the phenylephrine-mediated depolarization was not significantly altered by SCH23390 (91 ± 18% of control, n = 6, P > 0.1; Fig. 4B). The adrenergic antagonist, prazosin, produced a smaller, but statistically significant reduction of the dopamine (50–100 µM)-mediated depolarization by 25 ± 8% (n = 5, P < 0.05; Fig. 4B).



View larger version (44K):
[in this window]
[in a new window]
 
FIG. 4. At higher concentrations, dopamine activates {alpha}1-adrenergic receptors. Ai: in TTX (1 µM), the {alpha}-adrenergic agonist, phenylephrine (100 µM), produces a strong depolarization in a dLGN relay neuron. In the presence of the {alpha}1-adrenergic antagonist, prazosin (10 µM), the phenylephrine depolarization is strongly suppressed. ii: {alpha}2 adrenergic receptor agonist, clonidine (50 µM), did not alter the membrane potential or input resistance of a relay neuron. iii: {beta}-adrenergic receptor agonist, cimaterol (50 µM), did not alter the membrane potential or input resistance of a relay neuron. B: multiple actions of higher dopamine concentrations in relay neurons. The D1 receptor antagonist, SCH23390 (10 µM) significantly reduces the membrane depolarization produced by dopamine (**, P < 0.01). The noradrenergic antagonist, prazosin (10 µM), had a lesser but statistically significant (*, P < 0.05) effect on the dopamine-mediated depolarization, suggesting that at this concentration (50–100 µM), dopamine activates both D1-dopaminergic and {alpha}1-adrenergic receptors. On the other hand, the phenylephrine mediated depolarization is almost completely attenuated by the adrenergic antagonist, prazosin, whereas SCH23390 did not significantly alter the phenylephrine depolarization. C: in a different neuron, high dopamine concentration (200 µM) produces a strong depolarization in TTX (1 µM). In the presence of SCH23390 (10 µM), the depolarization is significantly reduced. However, the depolarization by 10 µM dopamine is completely attenuated in SCH23390. In the presence of prazosin (10 µM) and SCH23390, the high concentration dopamine-mediated depolarization is almost completely blocked. D: summary of population data for experiment outlined in C. The depolarization produced by high dopamine concentration (200 µM) is attenuated by 55 ± 19% in presence of SCH23390. The subsequent application of prazosin reduces the dopamine-mediated depolarization to 10 ± 5% of control. However, the depolarization produced by 10 µM is attenuated by 93 ± 4% in SCH23390 alone.

 
We further tested the potential cross talk of dopamine by using different dopamine concentrations (10 and 200 µM) in the presence of the D1-dopaminergic (SCH23390) and {alpha}1-adrenergic (prazosin) antagonists. Dopamine (200 µM) produced a depolarization that was significantly attenuated to 44 ± 19% of control by 10 µM SCH23390 (Fig. 4, C and D; P < 0.05, n = 6). Subsequent addition of prazosin (5 µM) further reduced the dopamine-mediated depolarization to 10 ± 5% of control (Fig. 4, C and D; P < 0.05, n = 6). In contrast, the depolarization produced by a lower dopamine concentration (10 µM), was reduced by 93 ± 4% (n = 4) in the presence of SCH23390 alone. The actions of these antagonists were partially reversible after a 15- to 25-min wash. Our data suggest that at lower concentrations, dopamine selectively activates D1-like receptors to depolarize thalamic relay neurons; however, at higher concentrations, dopamine also activates {alpha}1-adrenergic receptors to further depolarize the thalamic neurons.

Activation of D1-like receptors increases Ih in dLGN relay neurons

The ionic nature of the dopamine-mediated depolarization has not yet been identified in thalamic neurons. Given that the depolarization is associated with a weak increase in apparent input resistance, we initially tested the effect of the K+ channel blocker, Cs+. Using voltage-clamp recording techniques with a holding potential of –60 mV, dopamine (50 µM) produced an inward current (40.4 ± 21.2 pA, n = 15) consistent with the membrane depolarization observed using current-clamp recording techniques. Bath application of Cs+ (3 mM) significantly reduced the dopamine depolarization to 28.0 ± 9.0% of control (data not shown, n = 6, P < 0.05, Wilcoxon). However, extracellular Cs+ has been shown to not only block K+ currents, but also the hyperpolarization activated mixed cation current, Ih (Halliwell and Adams 1982Go; McCormick and Pape 1990bGo). We next used voltage-clamp recording techniques in conjunction with ramped voltage commands (–60 to –120 mV) to quantify alterations in input conductance. In TTX (1 µM), dopamine produced an inward current with an average peak of 47.6 ± 23.0 pA (n = 9). During the dopamine-mediated inward current, the slope of the current response was reduced in most cells (6/9, Fig. 5, A and B). Given the significant contribution of Ih to hyperpolarizing regions of the ramped voltage commands, we used the selective Ih blocker, ZD7288 (Fig. 5, A and B: +ZD7288). In ZD7288 (100 µM), the dopamine mediated inward current was significantly reduced to 27.8 ± 18.1% control (n = 9, P < 0.01, Wilcoxon) indicating that dopamine produces an increase in Ih that likely contributes to the membrane depolarization. In the presence of ZD7288, the remaining dopamine-sensitive current is linear (Fig. 5B: +ZD7288) and has an average reversal potential of –106 ± 31 mV (n = 9), indicative of Kleak. Thus our data suggest that the dopamine-mediated depolarization is composed of two components: an increase in Ih and a reduction in Kleak.



View larger version (40K):
[in this window]
[in a new window]
 
FIG. 5. Dopamine depolarizes thalamic neurons via activation of Ih. A: in a voltage-clamp recordings from a dLGN relay neuron, slow ramped voltage commands (–60 to –120 mV, 4-s duration, 10-s intervals) are used to assess conductance changes prior to and during dopamine application. Left: in TTX (1.0 µM), dopamine (50 µM) produces an inward current that recovers within a couple of minutes. Right: in the presence of the Ih channel blocker, ZD7288 (100 µM), dopamine produces a smaller inward current. B, left: each trace consists of an average of 6 subsequent responses prior to and at the peak of the dopamine-mediated inward current. After dopamine application, there is an inward shift in the current response to the voltage ramps. The difference between the dopamine (gray line) and predrug (black line) response is indicative of the dopamine-sensitive current (Idiff). In this case, this current is relatively flat with a very hyperpolarized reversal potential (more than –150 mV). However, in the presence of ZD7288 (right), the inward shift of the current response is partially attenuated. Furthermore, the dopamine-sensitive current, Idiff, is now linear with a reversal potential of –110 mV, near the calculated reversal for K+. These data suggest that the dopamine-mediated inward current results from increase in Ih and decrease in Kleak. C: in a different relay neuron, a lower dopamine concentration (10 µM) is tested. In this neuron, dopamine produces an inward current (left) that is completely attenuated in ZD7288 (right). D: similarly, the conductance change produced by dopamine (10 µM: left) is completely blocked in the presence of ZD7288 (100 µM: right).

 
Considering our earlier data that higher dopamine concentrations (>50 µM) can also activate {alpha}1-adrenergic receptors, we carried out the voltage-clamp experiments with lower dopamine concentrations. At 10 µM, dopamine produced a smaller but consistent inward current (12.7 ± 6.5 pA, n = 5) compared with 50 µM dopamine (Fig. 5C). In ZD7288 (100 µM), the dopamine mediated inward current was completely blocked (pre-ZD7288: 13.6 ± 7.3 pA, ZD7288: 0.5 ± 0.6 pA; n = 4, P < 0.05, paired t-test) indicating at low concentrations, the dopamine-mediated inward current results only from an increase in Ih (Fig. 5, C and D).

To specifically address the mechanism underlying the depolarizing response following activation of D1-like dopaminergic receptors, we repeated the voltage-clamp experiments using the selective agonist, SKF38393. With a holding potential of –60 mV in TTX (1 µM), SKF38393 produced an inward current that averaged 13.8 ± 8.2 pA (n = 7) associated with an apparent increase in conductance (Fig. 6A). Using slow ramped voltage commands, we analyzed the conductance change produced by SKF38393 by calculating the "resting" conductance of the cell prior to and after SKF38393 application in the linear response range of the neurons (Vhold: –60 to –80 mV, Fig. 6B). SKF38393 produced a significant increase in the neurons' conductance from 3.1 ± 0.9 nS to 3.6 ± 1.0 (n = 7; P < 0.01, paired t-test). We next tested the affect of the Ih blocker, ZD7288, on the SKF38393-mediated excitation. In ZD7288 (50–100 µM), the inward current produced by SKF38393 was strongly attenuated (Fig. 6A). In all four cells tested, the response to SKF38393 in the presence of ZD7288 averaged 0.1 ± 1.4 pA, a significant reduction of the inward current (P < 0.01, paired t-test). In addition, SKF38393 did not alter the conductance of the neurons in ZD7288 (2.02 ± 0.5 vs. 2.1 ± 0.5 nS, P > 0.3, n = 4). These data suggest that activation of D1-like dopaminergic receptors leads to an increase in Ih, which in turn accounts for the excitatory actions (inward current, membrane depolarization) of dopamine in thalamic relay neurons.



View larger version (52K):
[in this window]
[in a new window]
 
FIG. 6. SKF38393 depolarizes thalamic relay neurons via activation of Ih. A: in voltage-clamp recording from a dLGN relay neuron, slow ramped voltage commands (–60 to –120 mV) are used to measure conductance before and after SKF38393 application. In TTX (1 µM), the D1-agonist, SKF38393 (5 µM), produces an inward current associated with increases in membrane conductance. After application of ZD7288, the overall amplitude of the membrane responses to the voltage commands decreases as expected by the attenuation of Ih. The subsequent application of SKF38393 does not alter the holding current or the conductance of the neuron. B: expanded traces of the membrane response to the ramped voltage commands reveal not only the inward current but also the conductance increase by SKF38393 (gray trace). Each trace consists of an average of 6 subsequent responses prior to and at the peak of the SKF38393-mediated inward current in control (left) and in the presence of ZD7288 (right). The difference between the SKF38393 (gray trace) and predrug (black trace) is indicative of the SKF38393-sensitive current (Idiff). In control conditions, SKF38393 produces a nonlinear change in conductance with an extrapolated reversal potential near –40 mV. In ZD7288, the conductance change (Idiff) is completely blocked, indicating that SKF38393 leads to an activation of Ih.

 
Role of cAMP pathway in the depolarizing actions of dopamine

The D1-like dopamine receptors are positively coupled to the activation of adenylyl cyclase/cAMP/protein kinase A signal transduction pathway (Stoof and Kebabian 1984Go). We next tested whether the excitatory actions of dopamine on thalamic neurons involved the cAMP pathway. Bath application of the adenylyl cyclase (AC) activator, forskolin (0.5–20 µM, n = 21), produced a depolarization similar to SKF38393 (Fig. 7A). The peak amplitude of the depolarization averaged 2.5 ± 1.1 (n = 6), 3 ± 1 (n = 7), 3 ± 1 (n = 6), and 4.3 ± 1 mV (n = 10) at 0.5, 2, 5, and 20 µM forskolin (Fig. 7B). In contrast, when the phospholipase C inhibitor, U-73122 (200 µM), was included in the recording pipette, the dopamine-mediated depolarizations were not significantly altered (Fig. 7F; n = 8). These data indicate that activation of AC can depolarize thalamic relay neurons.



View larger version (39K):
[in this window]
[in a new window]
 
FIG. 7. Dopamine depolarizes dLGN relay neurons through a cAMP-dependent, protein kinase A (PKA)-independent signal transduction mechanism. A: in TTX, D1-like receptor agonist SKF38393 (10 µM) depolarizes a dLGN relay neuron. Subsequent application of the cAMP activator, forskolin (0.5 µM, 15 s), also produces a membrane depolarization that recovers after a few minutes. Application of a higher concentration of forskolin (20 µM) produces a larger depolarization. B: summary of dose-dependent action of forskolin on dLGN relay neurons. The number of cells tested at each concentration is listed. C: repeated application of dopamine (10 µM) produces a similar amplitude membrane depolarization in relay neurons. D: cAMP antagonist/PKA inhibitor, Rp-cAMP (500 µM), is included in the recording pipette. Within 2 min of forming the whole cell recording configuration, the initial application of dopamine (10 µM) produces a membrane depolarization; however, after 10 min, the subsequent application of dopamine produces a significantly smaller depolarization. Ei: in a different neuron, dopamine (10 µM) depolarizes the neuron. Bath application of the PKA inhibitor, KT5720 (2 µM), for 13 min did not alter the amplitude of the subsequent dopamine-mediated depolarization. Eii: in a different neuron, inclusion of KT5720 (10 µM) in the recording pipette did not affect the depolarization produced by dopamine (10 µM) within 2 min of break-in for whole cell recording configuration and 13 min later. In the same neuron, bath application of forskolin (25 µM) produced a large membrane depolarization. During the peak depolarization, the membrane potential is manually adjusted to preforskolin level (arrow), and the subsequent application of dopamine failed to depolarize the neuron. F: phospholipase C inhibitor, U-71322 (0.2 mM in pipette), did not attenuate dopamine-mediated depolarizations when applied at similar intervals as D and Eii. G: population data illustrating that the PKA inhibitor KT5720 did not significantly alter the depolarizing actions of dopamine (10 µM). H: population data illustrating that the antagonist Rp-cAMP (500 µM in recording pipette), significantly attenuated the dopamine mediated (10 µM) depolarizations. I: population data indicating that the dopamine-mediated depolarization is occluded in the presence of forskolin. The numbers in the plots indicate number of cells tested. A paired Student's t-test was used for statistical analyses (G–I).

 
We next tested the sensitivity of the dopamine-mediated depolarizations to inhibition of cAMP and protein kinase A (PKA). The cAMP analogue and PKA inhibitor, Rp-cAMP (500 µM), was included in the recording pipette. In control conditions (i.e., absence of Rp-cAMP in the pipette), dopamine (10–50 µM) was applied at 8–15 min intervals to test if the agonist could produce repeatable, consistent amplitude depolarizations (Fig. 7C). The responses to the first and second application did not differ significantly (7.7 ± 3.0 vs. 6.9 ± 2.0 mV; n = 6; P > 0.2, paired t-test). With the inclusion of Rp-cAMP in the recording pipette, we first applied dopamine within 2 min of forming the whole cell recording configuration and depolarization to this initial application averaged 4.8 ± 0.6 mV (n = 5; Fig. 7, D and H). After a 9- to 11-min interval, the subsequent application of dopamine produced a significantly smaller depolarization (1.6 ± 0.9 mV; n = 5; P < 0.1, paired t-test).

To test whether the dopamine-mediated depolarization involves cAMP-dependent PKA activation, we tested the sensitivity of the dopamine response to the selective PKA inhibitor, KT5720 (Huang and Hsu 2003Go; Kase et al. 1987Go). In control conditions, dopamine (10 µM) produced an average depolarization of 3.4 ± 1.1 mV (n = 5). The antagonist, KT5720 (1–5 µM), was applied for 8–15 min, and the subsequent dopamine application produced a similar depolarization (3.3 ± 1 mV) that did not significantly differ from the control response (Fig. 7, Ei and G; P > 0.1, paired t-test, n = 5). In a different series of experiments, KT5720 (10 µM) was included in recording pipettes. Using a similar experimental protocol as with Rp-cAMP, the initial dopamine-mediated depolarization (within 2 min after whole cell recording configuration) averaged 5.1 ± 0.9 mV (n = 4). The second dopamine application (13 min later) averaged 5.0 ± 0.5 mV and did not differ significantly from the first response (Fig. 7Eii, P > 0.1, paired t-test, n = 4). In same neurons, continuous bath application of cAMP agonist forskolin (25 µM, 5–10 min) produced a membrane depolarization that plateaued after a few minutes (Fig. 7F). The membrane potential was manually adjusted to the preforskolin level, and the subsequent dopamine application produced a significantly reduced depolarization (0.9 ± 0.2 mV; n = 4, Fig. 7Eii). The population data clearly indicate that the dopamine-mediated depolarization was significantly occluded following activation of cAMP by forskolin (Fig. 7I, P < 0.01, paired t-test, n = 4). These data suggest that the depolarizing action of dopamine via Ih is mediated through a cAMP-dependent, PKA-independent mechanism.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The major finding of our present study is that dopamine plays an important role in modulating the excitability of relay neurons in the dLGN. Although there are limited reports indicating that dopamine may alter sensory processing at the thalamic level, the underlying cellular mechanisms remain unknown. We have shown that dopamine and the specific D1-like receptor agonist, SKF38393, produce excitatory responses in dLGN relay neurons but not in dLGN interneurons. The D1-like receptor antagonist, SCH23390, attenuated the excitatory actions of dopamine. In contrast, D2-like receptor agonists did not alter the excitability of either relay neurons or interneurons. The activation of D1-like receptors led to an increase in Ih that is dependent on the activation of adenylyl cyclase and increased cAMP activity but independent of PKA activation. Interestingly, we found that dopamine, at lower concentrations, produced this specific action via D1-like receptors; however, at higher concentrations, dopamine also activated a1-adrenergic receptors, and via a decrease in Kleak, led to further depolarization of relay neurons (McCormick 1992bGo; McCormick and Prince 1988Go). Overall, our study indicates a potentially important role of D1-like receptors in influencing the excitability of thalamic relay neurons and ultimately modulating the gating properties of thalamic information transfer to the neocortex.

The h current (Ih) is a hyperpolarization-activated mixed cation current that was originally described in cardiac cells as If but has since been identified as Ih in a widespread variety of neural as well as nonneural cells (Brown and DiFrancesco 1980Go; Halliwell and Adams 1982Go; Pape 1996Go). In the thalamus, Ih has been well characterized in relay neurons and plays an integral role in the rhythmic activity of these neurons as well as an important contributor to the resting membrane potential (Lüthi and McCormick 1998Go; McCormick and Pape 1990aGo,bGo; Pape 1996Go). An interesting aspect of Ih is that this current can be directly modulated by alterations in cAMP activity (Frere and Luthi 2004Go; Kaupp and Seifert 2001Go; Pape 1996Go; Santoro and Tibbs 1999Go). Our data further support the modulatory role of Ih by cAMP in a PKA-independent manner. Considering activation of dopamine receptors is associated with changes in cAMP levels, it is not entirely surprising that dopamine may alter Ih activity. In other tissues, dopamine, via D2 receptors, has been found to decrease Ih (Akopian and Witkovsky 1996Go; Vargas and Lucero 1999Go). The novelty of our findings is the increase in Ih that we have observed in thalamic neurons is associated with activation of D1-like receptors.

Within the thalamus, a variety of neuromodulators, that arise from brain stem nuclei, have been found to alter Ih activity in relay neurons, including serotonin, norepinephrine, and histamine (McCormick and Pape 1990aGo; McCormick and Williamson 1991Go). The increase in Ih has been associated with increases in cAMP activity, and this may serve as a final common pathway for these neuromodulators. Our data add a newcomer to this list: dopamine. The activity of dopaminergic neurons in the mesencephalic reticular formation have been associated with a variety of arousing events such as novel stimuli and changes in the conditions of a salient environment (Horvitz 2000Go; Horvitz et al. 1997Go). The activity of noradrenergic neurons in the locus coeruleus are correlated with an organisms state of arousal (Aston-Jones et al. 1991Go; Hirsch et al. 1983Go; Livingstone and Hubel 1981Go; McCarley et al. 1983Go; Nakai and Takaori 1974Go; Rasmussen et al. 1986Go). Considering the release of these neuromodulators are associated with arousal levels, attention, and stimulus novelty, one hypothesis regarding a common function may be that these modulators tend to produce a heightened level of sensitivity, although further investigation regarding this idea is required.

Visual information is transferred from the retina to primary visual cortex via dLGN relay neurons. A variety of neurotransmitters/modulators that are released by intrathalamic neurons, corticothalamic neurons, as well as brain-stem-projecting neurons can modify neuronal excitability and thereby influence visual information that passes through the dLGN (Steriade et al. 1997Go). The predominant source of synaptic innervation of dLGN relay neurons is from nonretinal sources with only a small minority of synapses (<10%) that arise from retinal ganglion cells (Van Horn et al. 2000Go). These nonretinal, modulatory inputs can influence the excitability of thalamic circuits thereby altering the input/output function of the thalamus. In addition, these modulatory inputs may alter the action potential discharge mode of these neurons, which is related to the arousal state of the organism or novelty of the stimulus (Sherman and Guillery 1996Go, 2002Go; Steriade et al. 1993Go). For example, many neurotransmitters including acetylcholine, histamine, glutamate, serotonin, and norepinephrine clearly alter the excitability of relay neurons and transition the firing mode from a burst to tonic discharge mode (Cox and Sherman 2000Go; McCormick 1992bGo; Monckton and McCormick 2002Go; Turner and Salt 2000Go).

Dopaminergic innervation of the thalamus is relatively sparse compared with other catecholamines such as norepinephrine or serotonin, but nonetheless dopamine receptors are also present within the dLGN (Camps et al. 1990Go; Khan et al. 1998Go; Mijnster et al. 1999Go; Papadopoulos and Parnavelas 1990aGo). However, the functional role of dopamine in thalamic functioning is less established than that of the other catecholamines. Of the limited number of in vivo studies, dopamine tends to produce primarily inhibitory actions, that is, activation of dopaminergic receptors decreases the light-evoked as well as baseline activity of presumed relay neurons (Albrecht et al. 1996Go; Zhao et al. 2002Go). Dopamine has been shown to inhibit flash-evoked activity in the majority of rat dLGN neurons but can also facilitate the activity of other dLGN neurons (Albrecht et al. 1996Go). Dopamine has also been shown to produce concentration-dependent effects on visually evoked discharge of dLGN relay neurons: at high concentrations, dopamine suppresses the visual response but may facilitate the relay neuron activity at lower concentrations (Zhao et al. 2002Go). These previous in vivo studies have also suggested that dopamine may alter the activity of dLGN interneurons thereby decreasing relay neuron activity. In addition, the excitatory actions of dopamine have been associated with the activation of D2-like receptors, whereas the inhibitory actions may be due to activation of D1-like receptors (Albrecht et al. 1996Go; Zhao et al. 2002Go). Despite these generalizations of dopamine-mediated activity within the dLGN, it is clear that there are as many exceptions to these generalizations regarding the inhibitory and excitatory responses produced by dopamine in in vivo experiments.

Our study provides the first data demonstrating dopamine-mediated actions in dLGN thalamic relay neurons using intracellular recording techniques. We found that both dopamine and the D1 receptor agonist, SKF38393, produced robust membrane depolarizations in relay neurons only, whereas D2 receptor agonists, PPHT and bromocryptine, did not alter the membrane potential of relay neurons. Furthermore, we found no evidence that dopaminergic agonists alter the membrane potential of dLGN interneurons. Clearly, the excitatory actions of dopamine that we have observed using the in vitro slice preparation cannot easily account for the general findings reported in vivo. The inhibitory actions observed in vivo could arise from excitation of adjacent thalamic reticular nucleus neurons but do not appear to involve dLGN interneurons as originally suggested. Future studies should also focus on the possible actions of dopamine on synaptic activity. It is clear that further investigation at both the reduced level (in vitro preparation) and intact level (in vivo) are required to resolve these differences and ultimately understand the cellular mechanisms and functional significance regarding the role of dopamine in visual processing.


    GRANTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This research was supported by the National Institutes of Health Grants EY-014024 and NS-42356 and the Pharmaceutical Manufacturers Association of America Foundation.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: C. L. Cox, Dept. of Molecular and Integrative Physiology, University of Illinois, 2357 Beckman Institute, 405 N. Mathews Ave., Urbana, IL 61801 (E-mail: clcox{at}life.uiuc.edu)


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Akopian A and Witkovsky P. D2 dopamine receptor-mediated inhibition of a hyperpolarization-activated current in rod photoreceptors. J Neurophysiol 76: 1828–1835, 1996.[Abstract/Free Full Text]

Albrecht D, Quaschling U, Zippel U, and Davidowa H. Effects of dopamine on neurons of the lateral geniculate nucleus: an iontophoretic study. Synapse 23: 70–78, 1996.[CrossRef][ISI][Medline]

Aston-Jones G, Chiang C, and Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res 88: 501–520, 1991.[ISI][Medline]

Bourne JA. SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev 7: 399–414, 2001.[ISI][Medline]

Brown H and DiFrancesco D. Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit sino-atrial node. J Physiol 308: 331–351, 1980.[Abstract/Free Full Text]

Camps M, Kelly PH, and Palacios JM. Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species. J Neural Transm Gen Sect 80: 105–127, 1990.[CrossRef][ISI][Medline]

Cox CL and Sherman SM. Control of dendritic outputs of inhibitory interneurons in the lateral geniculate nucleus. Neuron 27: 597–610, 2000.[CrossRef][ISI][Medline]

De Lima AD, Montero VM, and Singer W. The cholinergic innervation of the visual thalamus: an EM immunocytochemical study. Exp Brain Res 59: 206–212, 1985.[ISI][Medline]

De Lima AD and Singer W. The serotoninergic fibers in the dorsal lateral geniculate nucleus of the cat: distribution and synaptic connections demonstrated with immunocytochemistry. J Comp Neurol 258: 339–351, 1987.[CrossRef][ISI][Medline]

Frere SG and Luthi A. Pacemaker channels in mouse thalamocortical neurones are regulated by distinct pathways of cAMP synthesis. J Physiol 554: 111–125, 2004.[Abstract/Free Full Text]

Govindaiah G and Cox CL. Synaptic activation of metabotropic glutamate receptors regulates dendritic outputs of thalamic interneurons. Neuron 41: 611–623, 2004.[CrossRef][ISI][Medline]

Hallanger AE, Levey AI, Lee HJ, Rye DB, and Wainer BH. The origins of cholinergic and other subcortical afferents to the thalamus in the rat. J Comp Neurol 262: 105–124, 1987.[CrossRef][ISI][Medline]

Halliwell JV and Adams PR. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res 250: 71–92, 1982.[CrossRef][ISI][Medline]

Hirsch JC, Fourment A, and Marc ME. Sleep-related variations of membrane potential in the lateral geniculate body relay neurons of the cat. Brain Res 259: 308–312, 1983.[CrossRef][ISI][Medline]

Horikawa K and Armstrong WE. A versatile means of intracellular labeling: injection of biocytin and its detection with avidin conjugates. J Neurosci Methods 25: 1–11, 1988.[CrossRef][ISI][Medline]

Horvitz JC. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96: 651–656, 2000.[CrossRef][ISI][Medline]

Horvitz JC, Stewart T, and Jacobs BL. Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat. Brain Res 759: 251–258, 1997.[CrossRef][ISI][Medline]

Huang CC and Hsu KS. Reexamination of the role of hyperpolarization-activated cation channels in short- and long-term plasticity at hippocampal mossy fiber synapses. Neuropharmacology 44: 968–981, 2003.[CrossRef][ISI][Medline]

Hughes HC and Mullikin WH. Brain stem afferents to the lateral geniculate nucleus of the cat. Exp Brain Res 54: 253–258, 1984.[ISI][Medline]

Jones EG. The Thalamus. New York: Plenum, 1985.

Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, and Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142: 436–440, 1987.[CrossRef][ISI][Medline]

Kaupp UB and Seifert R. Molecular diversity of pacemaker ion channels. Annu Rev Physiol 63: 235–257, 2001.[CrossRef][ISI][Medline]

Kayama Y. Ascending, descending and local control of neuronal activity in the rat lateral geniculate nucleus. Vision Res 25: 339–347, 1985.[CrossRef][ISI][Medline]

Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, and De La CA. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol 402: 353–371, 1998.[CrossRef][ISI][Medline]

Liu X-B, Honda CN, and Jones EG. Distribution of four types of synapse on physiologically identified relay neurons in the ventral posterior thalamic nucleus of the cat. J Comp Neurol 352: 69–91, 1995.[CrossRef][ISI][Medline]

Livingstone MS and Hubel DH. Effects of sleep and arousal on the processing of visual information in the cat. Nature 291: 554–561, 1981.[CrossRef][Medline]

Lüthi A and McCormick DA. H-current: properties of a neuronal and network pacemaker. Neuron 21: 9–12, 1998.[CrossRef][ISI][Medline]

McCarley RW, Benoit O, and Barrionuevo G. Lateral geniculate nucleus unitary discharge in sleep and waking: state- and rate-specific aspects. J Neurophysiol 50: 798–818, 1983.[Abstract/Free Full Text]

McCormick DA. Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus. J Neurosci 12: 278–289, 1992a.[Abstract]

McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol 39: 337–388, 1992b.[CrossRef][ISI][Medline]

McCormick DA and Pape H-C Noradrenergic and serotonergic modulation of a hyperpolarization-activated cation current in thalamic relay neurons. J Physiol 431: 319–342, 1990a.[Abstract/Free Full Text]

McCormick DA and Pape H-C Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurons. J Physiol 431: 291–318, 1990b.[Abstract/Free Full Text]

McCormick DA and Prince DA. Noradrenergic modulation of firing pattern in guinea pig and cat thalamic neurons, in vitro. J Neurophysiol 59: 978–996, 1988.[Abstract/Free Full Text]

McCormick DA and Williamson A. Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J Neurosci 11: 3188–3199, 1991.[Abstract]

Mijnster MJ, Isovich E, Flugge G, and Fuchs E. Localization of dopamine receptors in the tree shrew brain using [3H]-SCH23390 and [125I]-epidepride. Brain Res 841: 101–113, 1999.[CrossRef][ISI][Medline]

Millan MJ, Newman-Tancredi A, Quentric Y, and Cussac D. The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors. Psychopharmacology 156: 58–62, 2001.[CrossRef][Medline]

Monckton JE and McCormick DA. Neuromodulatory role of serotonin in the ferret thalamus. J Neurophysiol 87: 2124–2136, 2002.[Abstract/Free Full Text]

Morrison JH and Foote SL. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J Comp Neurol 243: 117–138, 1986.